Difesa Capital Management’s GeneDx Holdings WGS Stock Holding History

Difesa Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,576	Closed	-$91.3K	–	63
2023 Q1	$91.3K	Buy	7,576 +4,546	+150%	+$60.6K	0.06%	81
2022 Q4	$26.4K	Hold	3,030	–	–	0.02%	110
2022 Q3	$88K	Buy	3,030 +909	+43%	+$41.6K	0.04%	112
2022 Q2	$88K	Buy	+2,121	New	+$144K	0.05%	118

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Difesa Capital Management's WGS Position: Q2 2023 in Review

Difesa Capital Management sold out of GeneDx Holdings (WGS) in Q2 2023, closing a stake of 7,576 shares — an estimated $91.3K sold.

Difesa Capital Management first reported a position in WGS in Q2 2022 and held it in 4 quarters. The position peaked at $91.3K in Q1 2023. 58 funds tracked by Wall St. Rank hold WGS as of Q2 2023.

Difesa Capital Management reported no remaining GeneDx Holdings position as of Q2 2023 after selling out during the quarter.
Difesa Capital Management sold 7,576 GeneDx Holdings shares in Q2 2023, an estimated $91.3K.
Difesa Capital Management first reported a position in GeneDx Holdings in Q2 2022 and held it in 4 quarters.
Difesa Capital Management's GeneDx Holdings position peaked at $91.3K in Q1 2023.
58 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2023.

Based on Difesa Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.